These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3027929)

  • 1. Harmful effect of high stibogluconate treatment of kala-azar in India.
    Thakur CP
    Trans R Soc Trop Med Hyg; 1986; 80(4):672-3. PubMed ID: 3027929
    [No Abstract]   [Full Text] [Related]  

  • 2. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced ventricular tachycardia in kala-azar.
    Krishnan S; Tuteja A; Gupta HL; Prakash SK
    J Indian Med Assoc; 1987 Feb; 85(2):52-4. PubMed ID: 3039008
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient.
    Donovan KL; White AD; Cooke DA; Fisher DJ
    J Infect; 1990 Jul; 21(1):107-10. PubMed ID: 2166765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoplasia of bone marrow secondary to sodium antimony gluconate.
    Mallick BK
    J Assoc Physicians India; 1990 Apr; 38(4):310-1. PubMed ID: 2167887
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 9. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 10. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 13. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does antimony therapy cause bleeding in kala-azar patients and why?
    Chowdhury MA; Ahasan HA; Azhar MA; Rafiqueuddin AK; Islam MR; Misbahuddin M; Rashid MU
    Trop Doct; 1995 Oct; 25(4):188-9. PubMed ID: 7502336
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.
    Mishra M; Biswas UK; Jha AM; Khan AB
    Lancet; 1994 Dec; 344(8937):1599-600. PubMed ID: 7983993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal clearance of pentavalent antimony (sodium stibogluconate).
    Rees PH; Keating MI; Kager PA; Hockmeyer WT
    Lancet; 1980 Aug; 2(8188):226-9. PubMed ID: 6105394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Indian Kala-azar with pentavalent antimony.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Sambeat MA
    Lancet; 1995 Mar; 345(8949):584-5. PubMed ID: 7776793
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
    Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of kala-azar with sodium antimony-v-gluconate; preliminary observations.
    SEN GUPTA PC; CHAKRAVARTY NK
    Ind Med Gaz; 1945 Nov; 80(11):560-4. PubMed ID: 21022523
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.